Benzodiazepines, Umbilical Cord Tissue
Use
This test detects benzodiazepines and related metabolites in umbilical cord tissue as part of a comprehensive drug screen profile, to identify in utero exposure. Confirmation testing may be performed at no additional charge when appropriate. It is referred to NMS Labs for performance.
Special Instructions
Only orderable as a profile; see FCDSU / Comprehensive Drug Screen, Umbilical Cord Tissue. Confirmation testing may be performed at no additional charge.
Limitations
Reporting limits are determined for each analysis. All specimens will be evaluated by processing and performing laboratories for test suitability; no specific reject criteria beyond evaluation are provided.
Methodology
Other
Biomarkers
LOINC Codes
- 97212-5
- 97218-2
- 97228-1
- 97230-7
- 97238-0
- 97240-6
- 97250-5
- 97252-1
- 97258-8
- 97260-4
- 97278-6
- 97282-8
- 97322-2
- 97304-0
- 97308-1
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Tissue
Volume
Not provided
Minimum Volume
Not provided
Causes for Rejection
All specimens will be evaluated by the processing and performing laboratories for test suitability.
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 14 days |